Suchergebnisse - "Choueiri, T K"

PubPharm (94)

1

Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma : extended follow-up from the phase III randomised CheckMate 9ER trial

enthalten in: ESMO open | 2024

von Powles, T. | Burotto, M. | Escudier, B. | +17

2

The Double Antibody Drug Conjugate (DAD) phase I trial : sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von McGregor, B. | Sonpavde, G. | Kwak, L. | +11

3

Efficacy of avelumab plus axitinib versus sunitinib by numbers of IMDC risk factors and target tumor sites at baseline in advanced renal cell carcinoma : long-term follow-up results from JAVELIN Renal 101

enthalten in: ESMO open | 2023

von Tomita, Y. | Motzer, R. | Choueiri, T. | +9

4

COVID-19 in cancer patients : update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases

enthalten in: ESMO open | 2023

von Martin, P. | Tsourti, Z. | Ribeiro, J. | +22

5

Extended follow-up from JAVELIN Renal 101 : subgroup analysis of avelumab plus axitinib versus sunitinib by the International Metastatic Renal Cell Carcinoma Database Consortium risk group in patients with advanced renal cell carcinoma

enthalten in: ESMO open | 2023

von Haanen, J. | Larkin, J. | Choueiri, T. | +10

6

Association of C-reactive protein with efficacy of avelumab plus axitinib in advanced renal cell carcinoma : long-term follow-up results from JAVELIN Renal 101

enthalten in: ESMO open | 2022

von Tomita, Y. | Larkin, J. | Venugopal, B. | +10

7

Oncology clinical trial disruption during the COVID-19 pandemic : a COVID-19 and cancer outcomes study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Bakouny, Z. | Labaki, C. | Bhalla, S. | +33

8

COVID-19 in patients with cancer : first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)

enthalten in: ESMO open | 2022

von Castelo-Branco, L. | Tsourti, Z. | Gennatas, S. | +25

9

Efficacy and safety of avelumab plus axitinib in elderly patients with advanced renal cell carcinoma : extended follow-up results from JAVELIN Renal 101

enthalten in: ESMO open | 2022

von Tomita, Y. | Motzer, R. | Choueiri, T. | +9

10

COVID-19 vaccination and breakthrough infections in patients with cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Schmidt, A. | Labaki, C. | Hsu, C. | +40

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]